1,625
Views
69
CrossRef citations to date
0
Altmetric
Reviews

Characterization of host immune responses in Ebola virus infections

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shosaku Nomura, Takehito Taniura & Tomoki Ito. (2020) Extracellular Vesicle-Related Thrombosis in Viral Infection. International Journal of General Medicine 13, pages 559-568.
Read now
Raj Kumar Singh, Kuldeep Dhama, Yashpal Singh Malik, Muthannan Andavar Ramakrishnan, Kumaragurubaran Karthik, Rekha Khandia, Ruchi Tiwari, Ashok Munjal, Mani Saminathan, Swati Sachan, Perumal Arumugam Desingu, Jobin Jose Kattoor, Hafiz M.N. Iqbal & Sunil Kumar Joshi. (2017) Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey. Veterinary Quarterly 37:1, pages 98-135.
Read now
Christopher L Cooper, Karen A Martins, Sabrina M Stronsky, David P Langan, Jesse Steffens, Sean Van Tongeren & Sina Bavari. (2017) T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection. Emerging Microbes & Infections 6:1, pages 1-9.
Read now

Articles from other publishers (66)

Andrea Vucetic, Andrea Lafleur, Marceline Côté, Darwyn Kobasa, Mable Chan, Fernando Alvarez, Ciriaco Piccirillo, George Dong & Martin Olivier. (2023) Extracellular vesicle storm during the course of Ebola virus infection in primates. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Bryan T. Gemler, Chiranjit Mukherjee, Carrie A. Howland, Danielle Huk, Zachary Shank, Lela Johnson Harbo, Omar P. Tabbaa & Craig M. Bartling. (2022) Function-based classification of hazardous biological sequences: Demonstration of a new paradigm for biohazard assessments. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Sajad Fakhri, Pardis Mohammadi Pour, Sana Piri, Mohammad Hosein Farzaei & Javier Echeverría. (2021) Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals. Frontiers in Pharmacology 12.
Crossref
Yann Gallais, Raphaël Sierocki, Gautier Lhomme, Coline Sivelle, Divor Kiseljak, Florian Wurm, Sami Djoulah, Ahmed Bouzidi, Jérôme Kerzerho & Bernard Maillère. (2020) Large-scale mapping of the Ebola NP and GP proteins reveals multiple immunoprevalent and conserved CD4 T-cell epitopes. Cellular & Molecular Immunology 18:5, pages 1323-1325.
Crossref
Kendra J. Alfson, Yenny Goez-Gazi, Michal Gazi, Hilary Staples, Marc Mattix, Anysha Ticer, Benjamin Klaffke, Kaylee Stanfield, Priscilla Escareno, Patrick Keiser, Anthony Griffiths, Ying-Liang Chou, Nancy Niemuth, Gabe T. Meister, Chris M. Cirimotich & Ricardo CarrionJr.Jr.. (2021) Development of a Well-Characterized Rhesus Macaque Model of Ebola Virus Disease for Support of Product Development. Microorganisms 9:3, pages 489.
Crossref
Grazia Caleo, Foivi Theocharaki, Kamalini Lokuge, Helen A Weiss, Leena Inamdar, Francesco Grandesso, Kostas Danis, Biagio Pedalino, Gary Kobinger, Armand Sprecher, Jane Greig & Gian Luca Di Tanna. (2020) Clinical and epidemiological performance of WHO Ebola case definitions: a systematic review and meta-analysis. The Lancet Infectious Diseases 20:11, pages 1324-1338.
Crossref
Nicholas Di Paola, Mariano Sanchez-Lockhart, Xiankun Zeng, Jens H. Kuhn & Gustavo Palacios. (2020) Viral genomics in Ebola virus research. Nature Reviews Microbiology 18:7, pages 365-378.
Crossref
Shengnan Xu, Cuicui Jiao, Hongli Jin, Wujian Li, Entao Li, Zengguo Cao, Zhikang Shi, Feihu Yan, Shengnan Zhang, Hongbin He, Hang Chi, Na Feng, Yongkun Zhao, Yuwei Gao, Songtao Yang, Jianzhong Wang, Hualei Wang & Xianzhu Xia. (2019) A Novel Bacterium-Like Particle-Based Vaccine Displaying the SUDV Glycoprotein Induces Potent Humoral and Cellular Immune Responses in Mice. Viruses 11:12, pages 1149.
Crossref
Wakako FuruyamaAndrea Marzi. (2019) Ebola Virus: Pathogenesis and Countermeasure Development. Annual Review of Virology 6:1, pages 435-458.
Crossref
Joan Ponce, Yiqiang Zheng, Guang Lin & Zhilan Feng. (2019) Assessing the effects of modeling the spectrum of clinical symptoms on the dynamics and control of Ebola. Journal of Theoretical Biology 467, pages 111-122.
Crossref
Logan Banadyga, Vinayakumar Siragam, Wenjun Zhu, Shihua He, Keding Cheng & Xiangguo Qiu. (2019) The Cytokine Response Profile of Ebola Virus Disease in a Large Cohort of Rhesus Macaques Treated With Monoclonal Antibodies. Open Forum Infectious Diseases 6:3.
Crossref
Angelina Kakooza-Mwesige, Desire Tshala-Katumbay & Sharon L. Juliano. (2019) Viral infections of the central nervous system in Africa. Brain Research Bulletin 145, pages 2-17.
Crossref
Ping Cao, Haihong Bai, Xinghe Wang & Jinjing Che. (2018) Role of the Ebola membrane in the protection conferred by the three-mAb cocktail MIL77. Scientific Reports 8:1.
Crossref
Joanna Luczkowiak, Fatima Lasala, Marta Mora-Rillo, Jose R Arribas & Rafael Delgado. (2018) Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease. The Journal of Infectious Diseases 218:suppl_5, pages S574-S581.
Crossref
Gary Wong, Zirui Zhang, Shihua He, Marc-Antoine de La Vega, Kevin Tierney, Geoff Soule, Kaylie Tran, Lisa Fernando & Xiangguo Qiu. (2018) Marburg and Ravn Virus Infections Do Not Cause Observable Disease in Ferrets. The Journal of Infectious Diseases 218:suppl_5, pages S471-S474.
Crossref
Deepak KumarSulgey GauthamiMadala UmaKarthika NagalekshmiPavuluri Panduranga RaoAtanu BasuKrishna M. EllaNagendra R. Hegde. (2018) Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein . Viral Immunology 31:7, pages 500-512.
Crossref
Aroon Supramaniam, Hayman Lui, Bernadette M. Bellette, Penny A. Rudd & Lara J. Herrero. (2018) How myeloid cells contribute to the pathogenesis of prominent emerging zoonotic diseases. Journal of General Virology 99:8, pages 953-969.
Crossref
Lizette Elena Leiva-Suero, Jorge Marcelo Morales, Sandra Elizabeth Villacís-Valencia, Milagros Escalona-Rabaza, Graciela De las Mercedes Quishpe-Jara, Elena Vicenta Hernández-Navarro & Miriam Fernández-Nieto. (2018) Ébola, abordaje clínico integral. Revista de la Facultad de Medicina 66:3, pages 293-299.
Crossref
Abdulmannan Fadel, Andrew Plunkett, Weili Li, Vivian Elewosi Tessu Gyamfi, Rosemarie Roma Nyaranga, Fatma Fadel, Suaad Dakak, Yazan Ranneh, Yasser Salmon & Jason J Ashworth. (2018) Modulation of innate and adaptive immune responses by arabinoxylans. Journal of Food Biochemistry 42:2, pages e12473.
Crossref
Elisa Fanunza, Aldo Frau, Marco Sgarbanti, Roberto Orsatti, Angela Corona & Enzo Tramontano. (2018) Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling. Viruses 10:2, pages 98.
Crossref
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald, Ulrike Dirmeier, Cedric Cheminay, Ariane Volkmann, Trevor Brasel, Ricardo Carrion, Luis D. Giavedoni, Jean L. Patterson, Chad E. Mire, Thomas W. Geisbert, Jay W. Hooper, Mo Weijtens, Jutta Hartkoorn-Pasma, Jerome Custers, Maria Grazia Pau, Hanneke Schuitemaker & Roland Zahn. (2018) A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLOS ONE 13:2, pages e0192312.
Crossref
Olga Radinsky, Avishay Edri, Michael Brusilovsky, Shlomit Fedida-Metula, Ariel Sobarzo, Orly Gershoni-Yahalom, Julius Lutwama, John Dye, Leslie Lobel & Angel Porgador. (2017) Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI. Scientific Reports 7:1.
Crossref
Mark D. Kieh, Elim M. Cho & Ian A. Myles. (2017) Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak. PLOS ONE 12:6, pages e0179356.
Crossref
Ivan V. Kuzmin, Toni M. Schwarz, Philipp A. Ilinykh, Ingo Jordan, Thomas G. Ksiazek, Ravi Sachidanandam, Christopher F. Basler & Alexander Bukreyev. (2017) Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions. Journal of Virology 91:8.
Crossref
Marissa Balmith, Mbuso Faya & Mahmoud E. S. Soliman. (2017) Ebola virus: A gap in drug design and discovery - experimental and computational perspective. Chemical Biology & Drug Design 89:3, pages 297-308.
Crossref
Jonathan C. Guito, César G. Albariño, Ayan K. Chakrabarti & Jonathan S. Towner. (2017) Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system. Virology 501, pages 147-165.
Crossref
Ignacio S. Caballero, Anna N. Honko, Stephen K. Gire, Sarah M. Winnicki, Marta Melé, Chiara Gerhardinger, Aaron E. Lin, John L. Rinn, Pardis C. Sabeti, Lisa E. Hensley & John H. Connor. (2016) In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genomics 17:1.
Crossref
Joanna L. Miller, Simon G. Spiro, Stuart D. Dowall, Irene Taylor, Antony Rule, Dominic S. Alonzi, Andrew C. Sayce, Edward Wright, Emma M. Bentley, Ruth Thom, Graham Hall, Raymond A. Dwek, Roger Hewson & Nicole Zitzmann. (2016) Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model. PLOS ONE 11:11, pages e0167018.
Crossref
Vincent Madelain, Thi Huyen Tram Nguyen, Anaelle Olivo, Xavier de Lamballerie, Jérémie Guedj, Anne-Marie Taburet & France Mentré. (2016) Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials. Clinical Pharmacokinetics 55:8, pages 907-923.
Crossref
Ariel Sobarzo, Spencer Stonier, Andrew Herbert, David Ochayon, Ana Kuehne, Yael Eskira, Shlomit Fedida-Metula, Neta Tali, Eli Lewis, Moses Egesa, Stephen Cose, Julius Lutwama, Victoria Yavelsky, John Dye & Leslie Lobel. (2016) Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors. Viruses 8:5, pages 133.
Crossref
Alba Grifoni, Alessandra Lo Presti, Marta Giovanetti, Carla Montesano, Massimo Amicosante, Vittorio Colizzi, Alessia Lai, Gianguglielmo Zehender, Eleonora Cella, Silvia Angeletti & Massimo Ciccozzi. (2016) Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins. Asian Pacific Journal of Tropical Medicine 9:4, pages 337-343.
Crossref
C Agrati, C Castilletti, R Casetti, A Sacchi, L Falasca, F Turchi, N Tumino, V Bordoni, E Cimini, D Viola, E Lalle, L Bordi, S Lanini, F Martini, E Nicastri, N Petrosillo, V Puro, M Piacentini, A Di Caro, G P Kobinger, A Zumla, G Ippolito & M R Capobianchi. (2016) Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection. Cell Death & Disease 7:3, pages e2164-e2164.
Crossref
Joanna Luczkowiak, José R. Arribas, Sara Gómez, Víctor Jiménez-Yuste, Fernando de la Calle, Aurora Viejo & Rafael Delgado. (2016) Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus. Virus Research 213, pages 224-229.
Crossref
C. Raina MacIntyre & Abrar Ahmad Chughtai. (2016) Recurrence and reinfection—a new paradigm for the management of Ebola virus disease. International Journal of Infectious Diseases 43, pages 58-61.
Crossref
Alexandra Smirnova, Linda DeCamp & Hui Liu. 2016. Mathematical and Statistical Modeling for Emerging and Re-emerging Infectious Diseases. Mathematical and Statistical Modeling for Emerging and Re-emerging Infectious Diseases 103 121 .
Miguel J. Martínez, Abdulbaset M. Salim, Juan C. Hurtado & Paul E. Kilgore. (2015) Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infectious Diseases and Therapy 4:4, pages 365-390.
Crossref
Edgar Davidson, Christopher Bryan, Rachel H. Fong, Trevor Barnes, Jennifer M. Pfaff, Manu Mabila, Joseph B. Rucker & Benjamin J. Doranz. (2015) Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. Journal of Virology 89:21, pages 10982-10992.
Crossref
Azizul Haque, Didier Hober & Joel Blondiaux. (2015) Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks. Antimicrobial Agents and Chemotherapy 59:10, pages 5892-5902.
Crossref
Se-Ran Jun, Michael R. Leuze, Intawat Nookaew, Edward C. Uberbacher, Miriam Land, Qian Zhang, Visanu Wanchai, Juanjuan Chai, Morten Nielsen, Thomas Trolle, Ole Lund, Gregory S. Buzard, Thomas D. Pedersen, Trudy M. Wassenaar & David W. Ussery. (2015) Ebolavirus comparative genomics . FEMS Microbiology Reviews 39:5, pages 764-778.
Crossref
Arun Kharat. (2015) Ebola Fever and Advances in the Antiviral Therapies. Journal of Human Virology & Retrovirology 2:5.
Crossref
Jin Huk Choi, Kristina Jonsson-Schmunk, Xiangguo Qiu, Devon J. Shedlock, Jim Strong, Jason X. Xu, Kelly L. Michie, Jonathan Audet, Lisa Fernando, Mark J. Myers, David Weiner, Irnela Bajrovic, Lilian Q. Tran, Gary Wong, Alexander Bello, Gary P. Kobinger, Stephen C. Schafer & Maria A. Croyle. (2014) A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection. Molecular Pharmaceutics 12:8, pages 2712-2731.
Crossref
Jin Huk Choi, Stephen C. Schafer, Alexander N. Freiberg & Maria A. Croyle. (2015) Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine. Molecular Pharmaceutics 12:8, pages 2697-2711.
Crossref
Samson Sai-Yin Wong & Sally Cheuk-Ying Wong. (2015) Ebola virus disease in nonendemic countries. Journal of the Formosan Medical Association 114:5, pages 384-398.
Crossref
C. Raina MacIntyre, Abrar Ahmad Chughtai, Holly Seale, Guy A. Richards & Patricia M. Davidson. (2015) Uncertainty, risk analysis and change for Ebola personal protective equipment guidelines. International Journal of Nursing Studies 52:5, pages 899-903.
Crossref
Katharina B Lauer, Layla Faqih & Thomas J Blanchard. (2015) Long-term vaccine strategies for Ebola. The Lancet Infectious Diseases 15:5, pages 506-507.
Crossref
Alexander Gutfraind & Lauren Ancel Meyers. (2015) Evaluating Large-scale Blood Transfusion Therapy for the Current Ebola Epidemic in Liberia. The Journal of Infectious Diseases 211:8, pages 1262-1267.
Crossref
Judith N. Mandl & Mark B. Feinberg. (2015) Robust and sustained immune activation in human Ebola virus infection. Proceedings of the National Academy of Sciences 112:15, pages 4518-4519.
Crossref
Maria Rosaria Capobianchi, Elena Uleri, Claudia Caglioti & Antonina Dolei. (2015) Type I IFN family members: Similarity, differences and interaction. Cytokine & Growth Factor Reviews 26:2, pages 103-111.
Crossref
Eliana M. Coccia & Angela Battistini. (2015) Early IFN type I response: Learning from microbial evasion strategies. Seminars in Immunology 27:2, pages 85-101.
Crossref
Carl O. Eriksson, Timothy M. Uyeki, Michael D. Christian, Mary A. King, Dana A. V. Braner, Robert K. Kanter & Niranjan Kissoon. (2015) Care of the Child With Ebola Virus Disease*. Pediatric Critical Care Medicine 16:2, pages 97-103.
Crossref
Marc-Antoine de La VegaGary WongGary P. KobingerXiangguo Qiu. (2015) The Multiple Roles of sGP in Ebola Pathogenesis. Viral Immunology 28:1, pages 3-9.
Crossref
Haoyang Li, Tianlei Ying, Fei Yu, Lu Lu & Shibo Jiang. (2015) Development of therapeutics for treatment of Ebola virus infection. Microbes and Infection 17:2, pages 109-117.
Crossref
William Gallaher & Robert Garry. (2015) Modeling of the Ebola Virus Delta Peptide Reveals a Potential Lytic Sequence Motif. Viruses 7:1, pages 285-305.
Crossref
Samuel Ponce De Leon-Rosales, Rene Arredondo-Hernandez, Alejandro Macias & Richard P. Wenzel. (2015) Ebola, Through Air or Not Through Air: That is the Question. Frontiers in Public Health 2.
Crossref
Ariel Sobarzo, Yael Eskira, Andrew Herbert, Ana Kuehne, Spencer Stonier, David Ochayon, Shlomit Fedida-Metula, Steven Balinandi, Yaara Kislev, Neta Tali, Eli Lewis, Julius Lutwama, John Dye, Victoria Yavelsky & Leslie Lobel. (2015) Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks. Viruses 7:1, pages 37-51.
Crossref
Francesco Chiappelli, Andre Bakhordarian, April D Thames, Angela M Du, Allison L Jan, Melissa Nahcivan, Mia T Nguyen, Nateli Sama, Ercolano Manfrini, Francesco Piva, Rafael Rocha & Carl A Maida. (2015) Ebola: translational science considerations. Journal of Translational Medicine 13:1, pages 11.
Crossref
Eileen M. Burd. (2015) Ebola Virus: a Clear and Present Danger. Journal of Clinical Microbiology 53:1, pages 4-8.
Crossref
Jun Xu, DingYu Tan, YangYang Fu, Joseph Walline & XueZhong Yu. (2014) Do corticosteroids have a role in treating Ebola virus disease?. Science China Life Sciences 58:1, pages 111-113.
Crossref
Kang Yiu Lai, Wing Yiu George Ng & Fan Fanny Cheng. (2014) Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infectious Diseases of Poverty 3:1.
Crossref
Z. A. Stein, J. U. Tocco, J. E. Mantell & R. A. Smith. (2014) To hasten Ebola containment, mobilize survivors. International Journal of Epidemiology 43:6, pages 1679-1680.
Crossref
Aftab A. Ansari. (2014) Clinical features and pathobiology of Ebolavirus infection. Journal of Autoimmunity 55, pages 1-9.
Crossref
Denise J. Jamieson, Timothy M. Uyeki, William M. Callaghan, Dana Meaney-Delman & Sonja A. Rasmussen. (2014) What Obstetrician–Gynecologists Should Know About Ebola. Obstetrics & Gynecology 124:5, pages 1005-1010.
Crossref
Steve E Bellan, Juliet R C Pulliam, Jonathan Dushoff & Lauren Ancel Meyers. (2014) Ebola control: effect of asymptomatic infection and acquired immunity. The Lancet 384:9953, pages 1499-1500.
Crossref
HongWei Liang, Zhen Zhou, SuYang Zhang, Ke Zen, Xi Chen & ChenYu Zhang. (2014) Identification of Ebola virus microRNAs and their putative pathological function. Science China Life Sciences 57:10, pages 973-981.
Crossref
S Ng & B Cowling. (2014) Association between temperature, humidity and ebolavirus disease outbreaks in Africa, 1976 to 2014. Eurosurveillance 19:35, pages 20892.
Crossref
Andrew L. Webb, Brayden G. Schindell, Bryan D. Griffin, Geoff Soule, Abu B. Siddik, Bernard Abrenica, Harram Memon, Ruey-Chyi Su, Darwyn Kobasa, David Safronetz & Jason Kindrachuk. (2022) Persistent Ebola Virus Infection within the Male Reproductive Tract is Related to Both Viral Replication Kinetics and Host Response at the Blood-Testis Barrier. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.